詹云丽,林宇,罗东丽,杨小瑶
ZHAN Yunli,LIN Yu,LUO Dongli,YANG Xiaoyao

• 1:惠州市药品不良反应监测中心
• 2:广东省药品不良反应监测中心

摘要(Abstract)：

目的通过对惠州市2013年度基本药物不良反应监测数据进行统计和分析,关注其临床使用及不良反应发生情况,为基本药物的遴选提供参考。方法提取惠州市2013年药品不良反应网络管理平台的基本药物不良反应报告表进行统计分析。结果使用基本药物的ADR报告表有961份,共涉及1 116例次药品信息;来源主体为二级甲等医院,占45%;女病例多于男病例;0~10 a年龄段居多;引起不良反应的药品以抗微生物药物居多。结论加强基本药物不良反应监测,重点监测ADR多发品种,保障群众用药安全。
OBJECTIVE To analyze the data of essential medicine on adverse drug reaction monitoring in Huizhou,and pay attention to their clinical application and ADR,so as to provide reference for the selection of essential medicine. METHODS The adverse drug reaction( ADR) reports of essential drugs which occurred in Huizhou during 2013 were collected and statistically analyzed.RESULTS 961 ADR reports of essential medicine involved 1 116 cases of drug information. 45% of the reports came from secondarylevel hospital. Cases of female were more than those of male. Patients with 0-10 years old had the highest ADR occurrence rate. The drugs which caused adverse reaction were mainly antibacterial. CONCLUSION The ADR monitoring of essential medicine should be strengthened,and especially the ADR-prone varieties,so as to ensure the medication safety of the public.

关键词(KeyWords)： 基本药物;不良反应;数据分析
essential medicine;adverse drug reaction;data analysis

Abstract:

Keywords:

基金项目(Foundation): 2013年度惠州市技术研究与开发资金计划项目(2013B020006001)

作者(Author): 詹云丽,林宇,罗东丽,杨小瑶
ZHAN Yunli,LIN Yu,LUO Dongli,YANG Xiaoyao

参考文献(References)：

• [1]覃正碧,汪志宏,程刚,等.国家基本药物制度的现状及其完善对策探讨[J].中国药房,2008,19(14):1041-1044.
• [2]中华人民共和国卫生部.国家基本药物目录(2012年版)[Z].2012:1.
• [3]郭燕.对加强基本药物不良反应监测工作的思考[J].中国医药指南,2013,11(22):742.
• [4]中华人民卫生部.抗菌药物临床应用管理办法[Z].2012.
• [5]CFDA.国家基本药物目录管理办法(暂行)[EB/OL].http://www.sfda.gov.cn/WS01/CL0056/40754.html.
• [6]刘翠丽,侯永芳,宋秋杰,等.我国基本药物制度与药品不良反应监测关系的探讨[J].中国药物警戒,2013,10(6):335.